What does De Ceunynck Radiotherapy do?

De Ceunynck Radiotherapy is a wholesaler in Aartselaar. Public Limited, started on 28 August 2017, 1 establishment.

What is the address of De Ceunynck Radiotherapy?

The registered office of De Ceunynck Radiotherapy is located at Kontichsesteenweg 36, 2630 Aartselaar.

Is De Ceunynck Radiotherapy still active?

Yes. According to the CBE (31 October 2026) De Ceunynck Radiotherapy is active, legal situation “Normale toestand”, started on 28 August 2017.

Is De Ceunynck Radiotherapy registered on Peppol?

Yes, De Ceunynck Radiotherapy is registered on the Peppol network with ID 0208:0680604062.

What is the enterprise number of De Ceunynck Radiotherapy?

The enterprise number of De Ceunynck Radiotherapy is BE0680604062.

When was De Ceunynck Radiotherapy founded?

De Ceunynck Radiotherapy was founded on 28 August 2017.

Who are the directors of De Ceunynck Radiotherapy?

According to the 2025 annual accounts, the directors of De Ceunynck Radiotherapy are: Philippe Bettesone, Erik De Ceunynck, Peter Dejonge.

Is De Ceunynck Radiotherapy a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 August 2017; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did De Ceunynck Radiotherapy make in 2025?

De Ceunynck Radiotherapy recorded a loss after taxes of € 446,329 in financial year 2025.

What is the revenue of De Ceunynck Radiotherapy?

As a small company, De Ceunynck Radiotherapy is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -33,632.

How much does an employee at De Ceunynck Radiotherapy earn?

The average wage cost per full-time employee at De Ceunynck Radiotherapy was € 162,700 in 2025: staff costs of € 325,472 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does De Ceunynck Radiotherapy have?

According to the 2025 annual accounts, De Ceunynck Radiotherapy has 2 full-time equivalents (FTE).

De Ceunynck Radiotherapy (Public Limited) - Aartselaar

Dossier De Ceunynck Radiotherapy, printed on 1 November 2026 from databakkes.be/en/0680604062/de-ceunynck-radiotherapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 3 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
Shrinking team NBB

FTE fell two years in a row, from 3.5 to 2.

Financials

Financial year 2025

De Ceunynck Radiotherapy from Aartselaar, company number BE0680604062, closed financial year 2025 with a result of € -446,329 after tax. For that financial year De Ceunynck Radiotherapy recorded a gross margin of € -33,632 and equity of € -2 million. Compared with financial year 2024, the result moved from € -400,468 to € -446,329. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.

What it is worth Caution

€ -2 million

▼ € 446,329 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -446,329

▼ 11 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 67,468

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.1 million.

People and assets in 2025

Full-time equivalents

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 325,472

▼ 11% vs 2024

€ 162,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,080

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 631,155

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 35,595

▲ 28% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 766,484 Gross margin 2022: € 766,484 First fiscal year in the series	€ -155,483 Gross margin 2023: € -155,483 ▼ € 921,968 vs 2022 (€ 766,484) Unfavourable step	€ 82,766 Gross margin 2024: € 82,766 ▲ € 238,249 vs 2023 (€ -155,483) Favourable step	€ -33,632 Gross margin 2025: € -33,632 ▼ € 116,398 vs 2024 (€ 82,766) Unfavourable step	▼ € 116,398
Profit after taxes	€ 292,881 Profit after taxes 2022: € 292,881 First fiscal year in the series	€ -1,433,148 Profit after taxes 2023: € -1,433,148 ▼ € 1.7 million vs 2022 (€ 292,881) Unfavourable step	€ -400,468 Profit after taxes 2024: € -400,468 ▲ € 1 million vs 2023 (€ -1,433,148) Favourable step	€ -446,329 Profit after taxes 2025: € -446,329 ▼ € 45,861 vs 2024 (€ -400,468) Unfavourable step	▼ € 45,861
Equity	€ 233,512 Equity 2022: € 233,512 First fiscal year in the series	€ -1,199,637 Equity 2023: € -1,199,637 ▼ € 1.4 million vs 2022 (€ 233,512) Unfavourable step	€ -1,600,105 Equity 2024: € -1,600,105 ▼ € 400,468 vs 2023 (€ -1,199,637) Unfavourable step	€ -2,046,433 Equity 2025: € -2,046,433 ▼ € 446,329 vs 2024 (€ -1,600,105) Unfavourable step	▼ € 446,329
Total debts	€ 2,005,750 Total debts 2022: € 2,005,750 First fiscal year in the series	€ 1,979,642 Total debts 2023: € 1,979,642 ▼ 1% vs 2022 (€ 2,005,750) Favourable step	€ 2,235,125 Total debts 2024: € 2,235,125 ▲ 13% vs 2023 (€ 1,979,642) Unfavourable step	€ 2,523,649 Total debts 2025: € 2,523,649 ▲ 13% vs 2024 (€ 2,235,125) Unfavourable step	▲ 13%
Cash	€ 736,729 Cash 2022: € 736,729 First fiscal year in the series	€ 75,636 Cash 2023: € 75,636 ▼ 90% vs 2022 (€ 736,729) Unfavourable step	€ 92,000 Cash 2024: € 92,000 ▲ 22% vs 2023 (€ 75,636) Favourable step	€ 67,468 Cash 2025: € 67,468 ▼ 27% vs 2024 (€ 92,000) Unfavourable step	▼ 27%
Retained profit	€ 171,512 Retained profit 2022: € 171,512 First fiscal year in the series	€ -1,261,637 Retained profit 2023: € -1,261,637 ▼ € 1.4 million vs 2022 (€ 171,512) Unfavourable step	€ -1,662,105 Retained profit 2024: € -1,662,105 ▼ € 400,468 vs 2023 (€ -1,261,637) Unfavourable step	€ -2,108,433 Retained profit 2025: € -2,108,433 ▼ € 446,329 vs 2024 (€ -1,662,105) Unfavourable step	▼ € 446,329
Balance sheet total	€ 2,239,262 Balance sheet total 2022: € 2,239,262 First fiscal year in the series	€ 780,005 Balance sheet total 2023: € 780,005 ▼ 65% vs 2022 (€ 2,239,262) Unchanged	€ 635,020 Balance sheet total 2024: € 635,020 ▼ 19% vs 2023 (€ 780,005) Unchanged	€ 477,215 Balance sheet total 2025: € 477,215 ▼ 25% vs 2024 (€ 635,020) Unchanged	▼ 25%
Employees (FTE)	4 Employees (FTE) 2022: 4 First fiscal year in the series	3.5 Employees (FTE) 2023: 3.5 ▼ 0.5 vs 2022 (4) Unchanged	2.5 Employees (FTE) 2024: 2.5 ▼ 1 vs 2023 (3.5) Unchanged	2 Employees (FTE) 2025: 2 ▼ 0.5 vs 2024 (2.5) Unchanged	▼ 0.5

Key figures of De Ceunynck Radiotherapy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to De Ceunynck Radiotherapy?

What happened at De Ceunynck Radiotherapy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 30, 2026 New annual accounts for financial year 2025: loss of € 446,329. filed late Source: NBB ↗
2026 Philippe Bettesone became a director. NBB
2025 Peter Dejonge stepped down as director. NBB
Aug 28, 2017 New establishment in Aartselaar. KBO
Aug 28, 2017 Start of the company according to the CBE. KBO

In short

From € 292,881 profit in 2022 to € 446,329 loss in 2025.

Paid € 86,635 in corporate taxes since 2022.

Best year ever: 2022, with € 292,881 profit.

On average € 33,100 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

E & J 99%

The stake of E & J comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

De Ceunynck Radiotherapy

Behind De Ceunynck Radiotherapy are Philippe Bettesone and Erik De Ceunynck. The shares are held by E & J (99%).

Directors

According to the 2025 annual accounts

Philippe Bettesone

Managing director

since 2026

Erik De Ceunynck

Director

Also active at: De Ceunynck Services, DE CEUNYNCK MEDICAL

Peter Dejonge

Managing director

Also active at: E & J

· until 2025

Shareholders

E & J

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kontichsesteenweg 36

2630 Aartselaar

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

De Ceunynck Services same network

€ 1.7 million gross margin · 2025

VISION PARTNERS

€ -4,175 gross margin · 2025

DE CEUNYNCK MEDICAL same network

€ 14.4 million revenue · 2025

E & J same network

€ -4,387 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0680.604.062

VAT number

BE 0680.604.062

Registered office

Kontichsesteenweg 36, 2630 Aartselaar

Names & denominations

De Ceunynck Radiotherapy

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

28 August 2017

Peppol

Active · Active since 14 Nov 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Vervaardiging van overige farmaceutische producten

Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur

Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

De Ceunynck Radiotherapy

Warning lights

Financials

What happened to De Ceunynck Radiotherapy?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions